Target intelligence / Profile preview

GAF domain-containing protein

Molecular classification
Regulatory domain-containing protein, Allosteric modulator, Cyclic nucleotide-binding protein, Signal transduction protein, Other (GAF domains are present in several protein families including phosphodiesterases, adenylyl and guanylyl cyclases, phytochromes, and transcription factors[3][5][6])
01

Overview

A GAF domain-containing protein is defined by the presence of a GAF domain—a conserved protein module of approximately 150 amino acids, named for cGMP-specific phosphodiesterases, adenylyl cyclases, and FhlA[3][5][7][8]. These domains function as regulatory modules capable of binding small molecules (such as cyclic nucleotides), enabling allosteric modulation of protein activity. GAF domains are found in numerous proteins across bacteria, plants, and animals, especially in cyclic nucleotide phosphodiesterases (such as PDE2, PDE5, PDE6, PDE10, and PDE11 in mammals), where they mediate cyclic nucleotide-dependent regulation of enzymatic activity[4][5]. They are also present in sensory and signaling proteins such as phytochromes, adenylyl cyclases, and bacterial transcription factors[1][3][5]. Through ligand binding (for example cGMP or cAMP), GAF domains induce conformational rearrangements that regulate the activity of the host protein, impacting diverse biological processes including signal transduction, gene expression, sensory perception, and disease pathophysiology[2][4][5]. The GAF domain is evolutionarily related to the PAS domain, and both contribute to sensory and signaling functions in cells[5][6]. Drugs targeting GAF-domain containing phosphodiesterases—most notably PDE5 inhibitors—are established therapeutics for erectile dysfunction and pulmonary hypertension, while mutations in other GAF-domain proteins (such as PDE6B) are linked to inherited retinal diseases[6]. Given their central role in mediating responses to cyclic nucleotides, GAF domain-containing proteins are major regulators and therapeutic targets in physiology and disease[4][5].

Other names
GAF domain proteincGMP-specific phosphodiesterase domain proteincGMP receptor proteincyclic nucleotide-binding GAF protein
02

Mechanism of action

Allosteric inhibition of phosphodiesterases (by blocking cGMP/cAMP binding and thus regulating enzyme activity) Modulation of cyclic nucleotide levels, leading to downstream effects in vascular, neural, and reproductive tissues[4][5]

03

Biological functions

Signal transductionRegulation of gene expressionSensory perception (light, ethylene, or other signals)Allosteric modulation of enzyme activityRegulation of second messenger levels (cAMP, cGMP)Regulation of cellular processes such as cell cycle, development, and adaptation[2][4][5]
04

Disease associations

Cancer (through dysregulation of cAMP/cGMP pathways)Neurodegenerative diseaseCardiovascular disease (notably in smooth muscle and other tissues)Retinitis pigmentosa and congenital stationary night blindness (due to mutations in PDE6 GAF-domain proteins)[6]Other (numerous roles due to wide distribution)
05

Safety considerations

Ocular side effects (PDE6-related)Potential cardiovascular risks (PDE5 inhibition)Off-target signal transduction effects due to ubiquitous role of cyclic nucleotides
06

Interacting drugs

Sildenafil (Viagra™)

3 more in the full profile.

07

Biomarkers

cGMP or cAMP levels (indirect biomarkers for GAF-mediated PDE activity)Mutational status of PDE6A/B for retinal disease[6]PDE5 expression for certain cardiovascular and reproductive conditions

Beyond the preview

Go deeper on GAF domain-containing protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GAF domain-containing protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call